Biochemical changes following succinylcholine administration after pretreatment with rocuronium at different...

Area of Science:

• Anesthesiology and Pharmacology
• Biochemistry and Molecular Biology

Background:

• Succinylcholine administration can cause muscle fasciculations, leading to biochemical changes.
• Rocuronium is a neuromuscular blocking agent that may mitigate these effects.
• Understanding optimal pretreatment timing is crucial for patient safety.

Purpose of the Study:

• To investigate the biochemical alterations following succinylcholine administration.
• To assess the efficacy of rocuronium pretreatment at varying time intervals (1 vs. 5 minutes) in reducing these changes.

Main Methods:

• Prospective, randomized, single-blinded study involving 90 male patients undergoing elective surgery.
• Patients received either placebo, rocuronium 1 minute before succinylcholine, or rocuronium 5 minutes before succinylcholine.
• Serum levels of creatinine phosphokinase, lactate dehydrogenase, and myoglobin were measured at multiple time points post-succinylcholine.

Main Results:

• Rocuronium pretreatment significantly decreased serum creatinine phosphokinase and myoglobin levels compared to placebo.
• No significant difference in enzyme levels was found between the 1-minute and 5-minute rocuronium pretreatment groups.
• Lactate dehydrogenase levels significantly increased at 6 and 24 hours in the placebo group compared to rocuronium groups.

Conclusions:

• Rocuronium pretreatment effectively mitigates succinylcholine-induced biochemical changes, including muscle damage markers.
• The interval between rocuronium administration (1 or 5 minutes) does not significantly alter its protective effect.
• These findings support the use of rocuronium as a pretreatment to reduce succinylcholine-related myopathy.